Promising Treatment for Recently Diagnosed Type 1 Diabetes Receives JDRF Funding
Diamyd Medical and JDRF recently announced a four-year research and development collaboration focused largely on the Phase 3 trial of…
Our Research: Your Experience with T1D & Severe Hypoglycemia
Onlookers might think the scariest parts of living with type 1 diabetes (T1D) are the daily injections and the long-term…
Ask-a-Scientist: All About Autoimmunity & Type 1 Diabetes
Welcome to the first of our Ask-a-Scientist Series! A few weeks ago, we posed a question to our Online Community:…
Type 1 Diabetes Stem Cell Therapy Gets Greenlight for Human Trials
On March 9, 2023, Vertex Pharmaceuticals received FDA clearance to begin human trials with a new stem cell therapy, VX-264….
T1D Over a Lifetime: The Benefits of Longitudinal Research
Think back to the person you were in your teens. Can you recall what you thought your life would look…
The Color of Your Skin Should Not Affect Your Diabetes Care
The color of a person’s skin should not affect their diabetes care, but it still does. Despite so many advancements…
ATTD 2023 Research: The Impact of Diabetes Tech on Safety & Quality of Life
The 16th international ATTD (Advanced Technology and Treatments for Diabetes) conference was held in Berlin, Germany on February 22-25th. Despite…
Our Research: Your Mental Health with T1D Should Be Part of Routine Healthcare
Editor’s Note: If you are experiencing thoughts of self-harm or suicidal ideation, text the word “NAMI” to the National Alliance…
Cannabis Side-Effects Can Mimic DKA in People with Type 1 Diabetes
Editor’s Note: This article was written for awareness purposes only. T1D Exchange and the author do not endorse the use…
Our Top Research Highlights of 2022
2022 has been an amazing year for progress and growth for the T1D Exchange team. In the past year, the…
